Gallacher Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Buy |
12,573
+349
| +3% | +$13.4K | 0.22% | 130 |
|
|
2025
Q1 | $474K | Buy |
12,224
+943
| +8% | +$36.5K | 0.23% | 120 |
|
|
2024
Q4 | $382K | Buy |
11,281
+161
| +1% | +$5.45K | 0.19% | 145 |
|
|
2024
Q3 | $455K | Buy |
11,120
+356
| +3% | +$14.6K | 0.21% | 119 |
|
|
2024
Q2 | $414K | Buy |
10,764
+526
| +5% | +$20.3K | 0.22% | 120 |
|
|
2024
Q1 | $439K | Buy |
10,238
+223
| +2% | +$9.56K | 0.22% | 107 |
|
|
2023
Q4 | $371K | Buy |
10,015
+82
| +0.8% | +$3.04K | 0.21% | 122 |
|
|
2023
Q3 | $360K | Buy |
9,933
+174
| +2% | +$6.31K | 0.22% | 105 |
|
|
2023
Q2 | $348K | Buy |
9,759
+583
| +6% | +$20.8K | 0.2% | 139 |
|
|
2023
Q1 | $326K | Buy |
9,176
+1,399
| +18% | +$49.8K | 0.2% | 145 |
|
|
2022
Q4 | $273K | Buy |
+7,777
| New | +$273K | 0.17% | 154 |
|